PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Interview with Paul Rennie and Capital 51, page-17

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    Mmm.... maybe listen to it on a slow day when nothing better to do! No disrespect to Mozz but he and many others here are just way too invested in this company and i don't value their views as its just too biased. Timelines slipping, very poor insights into how much trials will cost etc etc just seem to be forgiven or swept under the rug. Either way, I've got my own views and insights which have served me very well in the past. Did anyone else notice the RRV publication date or comment on it? I had this days ago yet mgmt only release it today and gloss over a pretty significant issue (at least that i see) . No reason for me to comment on it, as with other negative aspects of the company - will be falling on deaf ears. my opinion
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
-0.015(6.98%)
Mkt cap ! $70.04M
Open High Low Value Volume
21.0¢ 21.0¢ 20.0¢ $201.6K 994.6K

Buyers (Bids)

No. Vol. Price($)
15 429247 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 13806 2
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.